Encompass Health Reaffirms 2024 Guidance Amid Market Volatility

Tuesday, 12 March 2024, 06:30
Encompass Health reiterated its anticipated financial performance targets for the year 2024, including projections for net operating revenue, adjusted EBITDA, and adjusted EPS. The announcement comes as a reassurance to investors amidst recent market fluctuations. The company's commitment to its stated guidance signals stability and a focus on long-term growth.
LivaRava Finance Meta Image
Encompass Health Reaffirms 2024 Guidance Amid Market Volatility

Encompass Health Reiterates 2024 Guidance

Encompass Health reaffirms its previously provided FY guidance, stating expected net operating revenue, adjusted EBITDA, and adjusted EPS figures.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe